InvestorsHub Logo
Followers 1
Posts 75
Boards Moderated 0
Alias Born 05/04/2013

Re: gotinearly post# 33625

Monday, 10/29/2018 4:45:48 PM

Monday, October 29, 2018 4:45:48 PM

Post# of 118384
HemaX was green lighted for Ph 1 in Dec 2015.

Nearly 3 years later, they have not started the trials. Have you ever heard of a biopharma getting the green light and not starting trials?

Why?

Could be that the company is insolvent?

Could be they are completely incompetent? ( i personally think not.... he's been cashing $300K every year for a long time )

Could be that the company shelved it as it was only a stock ploy?

or in the words of the well paid CEO:

"We were delighted that our licensees initiated this trial and that Regen could support them. It is gratifying to see that HemaXellerate may have some benefit to these patients," said Dr. David Koos, CEO. Tijuana, Mexico

"MAY HAVE SOME BENEFIT" = They know/knew it doesn't work.

Keep in mind, the entire self-stated premise of RGBP was to protect HemaX from hostile takeovers or make great deals down the road: A TOP PRIORITY.
IMO RGBP was created because BMSN was no longer a viable investable con.